Shiozaki joined the firm in 2024 as a venture partner and focuses on investment opportunities in biotech and medical devices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback